This article examines the mechanisms, potential risks, current evidence, and UK regulatory context to help you make an informed decision
Women using oral contraceptives should use an additional non-oral contraceptive method for 4 weeks after tirzepatide initiation and for 4 weeks after each dose escalation, as tirzepatide may reduce the effectiveness of oral contraceptives
Was the study performed in cells, animals or humans
On the other hand, compounded semaglutide is generally not covered by insurance
Food and Drug Administration, 2024 FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, FDA (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, FDA (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
-